English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Press Releases for Thursday, December 11, 2025
萬億工業賽道迎來「智慧樞紐」:解碼京東工業的價值邏輯 
22:20 HKT/SGT
国泰君安国际荣登《商业周刊》彭博绿金2026值得关注榜 - 绿色金融机构榜单 
22:10 HKT/SGT
國泰君安國際榮登《商業週刊》彭博綠金2026值得關注榜 - 綠色金融機構榜單 
22:01 HKT/SGT
國泰君安國際蟬聯《信報財經新聞》上市公司卓越大獎 
22:00 HKT/SGT
国泰君安国际蝉联《信报财经新闻》上市公司卓越大奖 
22:00 HKT/SGT
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China 
21:00 HKT/SGT
康哲藥業(0867)抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理 
20:01 HKT/SGT
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China 
20:00 HKT/SGT
康哲药业(0867)抗急性缺血性卒中创新药注射用Y-3中国NDA获受理 
19:53 HKT/SGT
Eisai Rated "A", the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year 
18:41 HKT/SGT
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing 
18:09 HKT/SGT
NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year 
18:00 HKT/SGT
京東工業即將登陸港股:萬億賽道的長期領跑者 
16:24 HKT/SGT
京东工业即将登陆港股:万亿赛道的长期领跑者 
16:05 HKT/SGT
贸易通与Fusion Bank签署合作备忘录 
14:40 HKT/SGT
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards 
12:54 HKT/SGT
CBL International Limited主席兼行政總裁謝威廉博士榮獲 香港董事學會「年度董事大獎」殊榮 
12:45 HKT/SGT
CBL International Limited主席兼行政总裁谢威廉博士荣获 香港董事学会"年度董事大奖"殊荣 
12:30 HKT/SGT
Honda、「N-BOX CUSTOM」に特別仕様車「BLACK STYLE」を設定し発売 
11:50 HKT/SGT
エーザイ、CDP より「気候変動」「水セキュリティ」分野で最高評価 A リストに 2 年連続でダブル選定 
11:50 HKT/SGT
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating 
08:20 HKT/SGT
撥康視雲股價飆升逾8成 多重利好催化迎價值重估 
08:20 HKT/SGT
拨康视云股价飙升逾8成 多重利好催化迎价值重估 
08:20 HKT/SGT
 ACN Search:
 
TANAKA's "Precious Metal Orchestra - A Musical Voyage through the Sound of Precious Metals for Christmas" now available for streaming at https://lnk.to/DLTA-8504
 
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575